ShaliniShenoyMD(She/Her)

Pediatric Hematology & Oncology • Saint Louis, MO

Pediatric Hematologic Oncology

Professor of Pediatrics, Director, Pediatric Transplant & Cellular Therapy, Washington University School of Medicine

Join to view full profile

Dr. Shenoy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shenoy's full profile

Already have an account?

Office
1 Childrens Pl
# Div
Saint Louis, MO 63110
Phone+1 314-454-6018

Fax+1 844-621-4392

Education & Training

Washington University/B-JH/SLCH ConsortiumFellowship, Pediatric Hematology/Oncology, 1992 - 1995
Louisiana State University School of MedicineResidency, Pediatrics, 1991 - 1991
Kasturba Medical College ManipalClass of 1981

Certifications & Licensure

MO State Medical License 1994 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
Completed
Phase 3
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201) Start of enrollment: 2004 Jan 01
Completed
Phase 3
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) Start of enrollment: 2005 Sep 01
Completed
Phase 2
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) Start of enrollment: 2008 Aug 01
Completed
Phase 2
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases Start of enrollment: 2001 Dec 01
Recruiting
Phase 1, Phase 2
Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
Completed
Reduced Intensity Transplant Conditioning Regimen for Severe Thalassemia Start of enrollment: 2010 Jan 01
Completed
Phase 2
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Natural History Study of SCID Disorders Start of enrollment: 2010 Sep 02
Enrolling by invitation
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2011 Apr 04
Completed
Phase 3
Patients Treated for SCID (1968-Present) Start of enrollment: 2011 May 15
Enrolling by invitation
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
Completed
Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease Start of enrollment: 2012 Jan 01
Active, not recruiting
Phase 2
Patients Treated for Wiskott-Aldrich Syndrome (WAS) Since 1990 Start of enrollment: 2014 Feb 02
Completed
Patients Treated for Chronic Granulomatous Disease (CGD) Since 1995 Start of enrollment: 2014 Jun 01
Enrolling by invitation
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507) Start of enrollment: 2017 Oct 03
Active, not recruiting
Phase 2
Roles: Contact
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders Start of enrollment: 2017 Mar 20
Recruiting
Phase 1, Phase 2
Roles: Contact, Principal Investigator
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV) Start of enrollment: 2018 Nov 01
Recruiting
Phase 2
Roles: Contact
Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors Start of enrollment: 2019 Apr 03
Active, not recruiting
Roles: Principal Investigator, Contact
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis Start of enrollment: 2022 Mar 30
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection Start of enrollment: 2018 Nov 01
Recruiting
Phase 2
Roles: Contact
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection Start of enrollment: 2020 Jul 07
Recruiting
Phase 2
Roles: Contact
Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs) Start of enrollment: 2020 Jul 01
Recruiting
Phase 1, Phase 2
Roles: Contact
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors Start of enrollment: 2020 Dec 08
Recruiting
Not Applicable
Roles: Contact
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202) Start of enrollment: 2023 Jan 25
Recruiting
Phase 3
Roles: Contact
Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation Start of enrollment: 2019 Mar 22
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation.
Thomas Pfeiffer, Christine R Lockowitz, Shalini Shenoy, Melissa Mavers, Robert Hayashi
Bone Marrow Transplantation. 2024-08-01
Barriers and Facilitators to Youth Decision-Making Involvement in Families Referred for Stem Cell Transplant.
Ginny Lynn Schulz, Angela Christine Painter, Amy McQueen, Shalini Shenoy, James M DuBois
Journal of Family Nursing. 2024-08-01
The Adverse Event Landscape of Stem Cell Transplant: Evidence for aGVHD Driving Early Transplant Associated Toxicities.
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2024-04-06

Journal Articles

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow T...
Shenoy S, Gaziev J, Angelucci E, King A, Bhatia M, Smith A, Bresters D, Haight AE, Duncan CN, de la Fuente J, Dietz AC, Baker KS, Pulsipher MA, Walters MC., Biology of Blood and Marrow Transplant
Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204
Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood